Researchers move closer to producing heparin in the lab

In a recent study published in the Proceedings of the National Academy of Sciences (PNAS), University of California San Diego researchers moved one step closer to the ability to make heparin in cultured cells. Heparin is ...

Potent alpaca nanobodies neutralize SARS-CoV-2 variants

Researchers at Karolinska Institutet in Sweden have developed a novel strategy for identifying potent miniature antibodies, so-called nanobodies, against emerging SARS-CoV-2 variants. The approach led to the discovery of ...

Searching for an ancient syphilis DNA in newborns

The ancient bones of newborns are very useful to recover the ancient DNA of the bacteria causing syphilis, the Treponema pallidum pallidum. This is the conclusion reached by a study led by Universitat Autonoma de Barcelona ...

Nanosponges could intercept SARS-CoV-2 coronavirus infection

Nanoparticles cloaked in human lung cell membranes and human immune cell membranes can attract and neutralize the SARS-CoV-2 virus in cell culture, causing the virus to lose its ability to hijack host cells and reproduce.

First successful total synthesis of Erythropoietin

(Phys.org)—"Blood is quite a peculiar kind of juice"—that is what Mephisto knew, according to Goethe's "Faust". But if blood really is very special, then erythropoietin (EPO) must be a very special molecule, as it triggers ...

page 2 from 33